Efficacy and safety of eculizumab-combined therapy for patients with anti-GBM disease.
BACKGROUND The study aimed to evaluate the efficacy and safety of eculizumab in addition to conventional therapy for anti-glomerular basement membrane (anti-GBM) disease presenting rapidly progressive glomerulonephritis (RPGN). METHODS 42 patients with anti-GBM disease presenting with RPGN were included in this multi...